Clashes, Turmoil and Paranoia: Inside Trump’s FDA
Marty Makary’s ideal image isn’t aging well
This article is for subscribers only.
Welcome back to Bloomberg’s Health Monitor, a weekly look at the boardroom decisions, scientific advances and policy fights shaping the future of medicine. Sign up now if you’re not already on the list.
Lilly’s Mounjaro has overtaken “King Keytruda” as the best-selling drug in the world, as pharmaceutical companies including Bristol Myers, Moderna and Pfizer posted strong results for the first quarter.